India To Set Up CRISPR Innovation Centre In Bengaluru
Technology

India To Set Up CRISPR Innovation Centre In Bengaluru

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions.

The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions.

The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem.

Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions. The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions. The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem. Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

Next Story
Real Estate

Modon, Related, Panepinto form JV for Harborside 4 in Jersey City

Abu Dhabi-based Modon Holding PSC has formed a joint venture with US real estate major Related Companies and Jersey City-based Panepinto Properties to develop Harborside 4, a 54-storey luxury residential tower on a prime waterfront site in downtown Jersey City, New Jersey.Under the partnership, Modon will hold a majority equity stake alongside Related and Panepinto, marking another step in the group’s strategy to scale and diversify its global real estate portfolio. The project will be developed on one of the last remaining premium waterfront parcels in the city.Designed by Handel Architects..

Next Story
Infrastructure Urban

P+Ex and Post-Tensioning Institute partner to drive sustainability

P+Ex, the Center of Excellence for Concrete Preservation and Service Life Extension, has announced a strategic partnership with the Post-Tensioning Institute (PTI) aimed at advancing sustainability, durability, and resilience in the built environment.The collaboration brings together P+Ex’s expertise in concrete preservation, repair, and service life extension with PTI’s global leadership in post-tensioning technology. Through this alliance, the two organisations will work to advance best practices in durability-focused design for new structures, while also promoting effective repair, reha..

Next Story
Infrastructure Energy

India’s Largest 2,000 MW Subansiri Hydro Project Turns Operational

India’s largest hydropower project, the 2,000 MW Subansiri Lower Hydroelectric Project, has finally become operational with the commissioning of its first unit, marking a major milestone after nearly 20 years of development marked by delays, protests and cost escalation.The 250 MW Unit-2 of the project, located on the Subansiri River at Gerukamukh on the Assam–Arunachal Pradesh border, was virtually inaugurated from New Delhi by Union Minister of Power Manohar Lal Khattar. The event was attended by Pankaj Agarwal, Secretary (Power), and Bhupender Gupta, Chairman and Managing Director, Nati..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App